CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT (Unaudited) - USD ($) $ in Thousands |
Total |
Common Stock [Member] |
Additional Paid-In-Capital [Member] |
Accumulated Deficit [Member] |
Accumulated Other Comprehensive Income (Loss) [Member] |
Redeemable Convertible Preferred Stock |
| Beginning balance at Dec. 31, 2022 |
|
|
|
|
|
$ 288,304
|
| Beginning balance (in shares) at Dec. 31, 2022 |
|
|
|
|
|
241,828,956
|
| Beginning balance at Dec. 31, 2022 |
$ (213,087)
|
|
$ 12,836
|
$ (225,592)
|
$ (331)
|
|
| Beginning balance, (in shares) at Dec. 31, 2022 |
|
333,330
|
|
|
|
|
| Issuance of Series G preferred shares, net of offering costs |
|
|
|
|
|
$ 31,258
|
| Issuance of Series G preferred shares, net of offering costs (in shares) |
|
|
|
|
|
34,972,704
|
| Exercise of warrants (in shares) |
|
|
|
|
|
437,319
|
| Exercise of warrants |
|
|
|
|
|
$ 599
|
| Exercise of stock options |
$ 276
|
|
276
|
|
|
|
| Exercise of stock options (in shares) |
23,101
|
23,056
|
|
|
|
|
| Stock-based compensation |
$ 2,623
|
|
2,623
|
|
|
|
| Deemed dividend |
|
|
1,941
|
(1,941)
|
|
|
| Currency translation adjustment |
(508)
|
|
|
|
(508)
|
|
| Net loss |
(50,332)
|
|
|
(50,332)
|
|
|
| Ending balance at Dec. 31, 2023 |
320,161
|
|
|
|
|
$ 320,161
|
| Ending balance (in shares) at Dec. 31, 2023 |
|
|
|
|
|
277,238,979
|
| Ending balance at Dec. 31, 2023 |
(261,028)
|
|
17,676
|
(277,865)
|
(839)
|
|
| Ending balance, (in shares) at Dec. 31, 2023 |
|
356,356
|
|
|
|
|
| Issuance of Series G preferred shares, net of offering costs |
|
|
|
|
|
$ 57,983
|
| Issuance of Series G preferred shares, net of offering costs (in shares) |
|
|
|
|
|
64,257,179
|
| Issuance of warrants |
1,940
|
|
1,940
|
|
|
|
| Exercise of stock options |
349
|
|
349
|
|
|
|
| Exercise of stock options (in shares) |
|
19,015
|
|
|
|
|
| Stock-based compensation |
4,311
|
|
4,311
|
|
|
|
| Deemed dividend |
|
|
2,724
|
(2,724)
|
|
|
| Currency translation adjustment |
107
|
|
|
|
107
|
|
| Net loss |
(29,470)
|
|
|
(29,470)
|
|
|
| Ending balance at Sep. 30, 2024 |
|
|
|
|
|
$ 378,144
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
|
|
|
341,496,158
|
| Ending balance at Sep. 30, 2024 |
(283,791)
|
|
27,000
|
(310,059)
|
(732)
|
|
| Ending balance, (in shares) at Sep. 30, 2024 |
|
375,371
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
320,161
|
|
|
|
|
$ 320,161
|
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
|
|
|
277,238,979
|
| Beginning balance at Dec. 31, 2023 |
$ (261,028)
|
|
17,676
|
(277,865)
|
(839)
|
|
| Beginning balance, (in shares) at Dec. 31, 2023 |
|
356,356
|
|
|
|
|
| Issuance of Series G preferred shares, net of offering costs |
|
|
|
|
|
$ 57,989
|
| Issuance of Series G preferred shares, net of offering costs (in shares) |
|
|
|
|
|
64,257,179
|
| Conversion of redeemable convertible preferred stock to common stock on initial public offering, Shares |
12,729,349
|
|
|
|
|
|
| Issuance of warrants |
$ 1,940
|
|
1,940
|
|
|
|
| Exercise of stock options |
$ 854
|
|
854
|
|
|
|
| Exercise of stock options (in shares) |
78,377
|
78,365
|
|
|
|
|
| Stock-based compensation |
$ 5,174
|
|
5,174
|
|
|
|
| Deemed dividend |
|
|
2,724
|
(2,724)
|
|
|
| Currency translation adjustment |
319
|
|
|
|
319
|
|
| Net loss |
(39,661)
|
|
|
(39,661)
|
|
|
| Ending balance at Dec. 31, 2024 |
378,150
|
|
|
|
|
$ 378,150
|
| Ending balance (in shares) at Dec. 31, 2024 |
|
|
|
|
|
341,496,158
|
| Ending balance at Dec. 31, 2024 |
(292,402)
|
|
28,368
|
(320,250)
|
(520)
|
|
| Ending balance, (in shares) at Dec. 31, 2024 |
|
434,720
|
|
|
|
|
| Beginning balance at Jun. 30, 2024 |
|
|
|
|
|
$ 371,657
|
| Beginning balance (in shares) at Jun. 30, 2024 |
|
|
|
|
|
334,307,317
|
| Beginning balance at Jun. 30, 2024 |
(276,587)
|
|
24,517
|
(300,316)
|
(788)
|
|
| Beginning balance, (in shares) at Jun. 30, 2024 |
|
372,686
|
|
|
|
|
| Issuance of Series G preferred shares, net of offering costs |
|
|
|
|
|
$ 6,487
|
| Issuance of Series G preferred shares, net of offering costs (in shares) |
|
|
|
|
|
7,188,841
|
| Exercise of stock options |
56
|
|
56
|
|
|
|
| Exercise of stock options (in shares) |
|
2,685
|
|
|
|
|
| Stock-based compensation |
2,122
|
|
2,122
|
|
|
|
| Deemed dividend |
|
|
305
|
(305)
|
|
|
| Currency translation adjustment |
56
|
|
|
|
56
|
|
| Net loss |
(9,438)
|
|
|
(9,438)
|
|
|
| Ending balance at Sep. 30, 2024 |
|
|
|
|
|
$ 378,144
|
| Ending balance (in shares) at Sep. 30, 2024 |
|
|
|
|
|
341,496,158
|
| Ending balance at Sep. 30, 2024 |
(283,791)
|
|
27,000
|
(310,059)
|
(732)
|
|
| Ending balance, (in shares) at Sep. 30, 2024 |
|
375,371
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
378,150
|
|
|
|
|
$ 378,150
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
|
341,496,158
|
| Beginning balance at Dec. 31, 2024 |
(292,402)
|
|
28,368
|
(320,250)
|
(520)
|
|
| Beginning balance, (in shares) at Dec. 31, 2024 |
|
434,720
|
|
|
|
|
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering, Shares |
|
|
|
|
|
(341,496,158)
|
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering, value |
|
|
|
|
|
$ (378,150)
|
| Conversion of redeemable convertible preferred stock to common stock on initial public offering, Shares |
|
12,729,240
|
|
|
|
|
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering, value |
378,150
|
|
378,150
|
|
|
|
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares) |
|
4,600,000
|
|
|
|
|
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions, Value |
99,843
|
|
99,843
|
|
|
|
| Settlement of warrant liability |
173
|
|
173
|
|
|
|
| Exercise of warrants (in shares) |
|
435,013
|
|
|
|
|
| Exercise of warrants |
5,702
|
|
5,702
|
|
|
|
| Exercise of stock options |
353
|
|
353
|
|
|
|
| Exercise of stock options (in shares) |
|
39,489
|
|
|
|
|
| Stock-based compensation |
3,684
|
|
3,684
|
|
|
|
| Currency translation adjustment |
66
|
|
|
|
66
|
|
| Net loss |
(25,782)
|
|
|
(25,782)
|
|
|
| Ending balance at Sep. 30, 2025 |
0
|
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
169,787
|
|
516,273
|
(346,032)
|
(454)
|
|
| Ending balance, (in shares) at Sep. 30, 2025 |
|
18,238,462
|
|
|
|
|
| Beginning balance at Jun. 30, 2025 |
|
|
|
|
|
$ 378,150
|
| Beginning balance (in shares) at Jun. 30, 2025 |
|
|
|
|
|
341,496,158
|
| Beginning balance at Jun. 30, 2025 |
(307,311)
|
|
30,159
|
(337,030)
|
(440)
|
|
| Beginning balance, (in shares) at Jun. 30, 2025 |
|
450,682
|
|
|
|
|
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering, Shares |
|
|
|
|
|
(341,496,158)
|
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering, value |
|
|
|
|
|
$ (378,150)
|
| Conversion of redeemable convertible preferred stock to common stock on initial public offering, Shares |
|
12,729,240
|
|
|
|
|
| Conversion of redeemable convertible preferred stock into common stock in connection with initial public offering, value |
378,150
|
|
378,150
|
|
|
|
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions (in shares) |
|
4,600,000
|
|
|
|
|
| Issuance of common stock in connection with initial public offering, net of offering costs, underwriting discounts and commissions, Value |
99,843
|
|
99,843
|
|
|
|
| Settlement of warrant liability |
173
|
|
173
|
|
|
|
| Exercise of warrants (in shares) |
|
435,013
|
|
|
|
|
| Exercise of warrants |
5,702
|
|
5,702
|
|
|
|
| Exercise of stock options |
178
|
|
178
|
|
|
|
| Exercise of stock options (in shares) |
|
23,527
|
|
|
|
|
| Stock-based compensation |
2,068
|
|
2,068
|
|
|
|
| Currency translation adjustment |
(14)
|
|
|
|
(14)
|
|
| Net loss |
(9,002)
|
|
|
(9,002)
|
|
|
| Ending balance at Sep. 30, 2025 |
0
|
|
|
|
|
|
| Ending balance at Sep. 30, 2025 |
$ 169,787
|
|
$ 516,273
|
$ (346,032)
|
$ (454)
|
|
| Ending balance, (in shares) at Sep. 30, 2025 |
|
18,238,462
|
|
|
|
|